FDA NDC Directory · JSON-LD · Markdown

Remodulin

NDC 66302-101 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nametreprostinil
Labeler / ManufacturerUnited Therapeutics Corporation
Marketing categoryNew Drug Application (innovator) · App NDA021272
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS SUBCUTANEOUS
Active ingredientsTREPROSTINIL (20 mg/20mL)
Marketing started20020522
Package count1

External sources

Source: openFDA. Public-domain (CC0).